PMID: 8942862Nov 1, 1996Paper

The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey

Ophthalmology
B RahmaniA Sommer

Abstract

Whereas population-based data on the causes of bilateral blindness have been reported, little information is available on the distribution of causes of central vision loss less severe than the criteria used to define legal blindness. This visual impairment is responsible for a high proportion of eye care service use and results in important reductions in functional status. Data from the Baltimore Eye Survey were used to estimate the cause-specific prevalence of visual impairment (best-corrected visual acuity worse than 20/40 but better than 20/200) among black and white residents of east Baltimore who were 40 years of age or older. Eligible subjects underwent a screening examination at a neighborhood location and, for those whose best-corrected visual acuity was less than 20/30, a definitive ophthalmologic examination at the Wilmer Eye Institute. The prevalence of visual impairment was 2.7% in whites and 3.3% in blacks; the age-adjusted relative prevalence (B/W) was 1.75 (P = 0.01). The leading causes of visual impaired eyes were cataract (35.8%), age-related macular degeneration (14.2%), diabetic retinopathy (6.6%), glaucoma (4.7%), and other retinal disorders (7.3%). Cataract, diabetic retinopathy, and glaucoma were more comm...Continue Reading

Associated Clinical Trials

Feb 19, 2018·Xiaomin Zhang

References

Nov 14, 1991·The New England Journal of Medicine·A SommerS Ezrine
Aug 1, 1991·Ophthalmology·R KleinD L De Mets
Jan 1, 1985·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·W N Charman
Apr 1, 1982·Archives of Ophthalmology·B E Klein, R Klein
May 1, 1980·Survey of Ophthalmology·D E KreugerL R Maunder

❮ Previous
Next ❯

Citations

Aug 23, 2007·International Ophthalmology·Margaret A ChangAlfred Sommer
Nov 21, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J J Navarro EstebanV Martínez-Vizcaíno
Jun 1, 2005·The Medical Clinics of North America·M Roy Wilson, Deborah R Eezzuduemhoi
Feb 10, 2004·Progress in Retinal and Eye Research·Neville N OsborneJosé Melena
Feb 28, 2002·American Journal of Ophthalmology·Harry A QuigleyIrvin P Pollack
Oct 8, 1999·American Journal of Ophthalmology·M M BrownG Shah
May 15, 2003·Survey of Ophthalmology·Lyne RacettePamela A Sample
Oct 12, 2000·Eye·G L Spaeth, M L Marques Pereira
Apr 17, 2004·International Ophthalmology Clinics·Christopher A Girkin
Apr 17, 2007·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Robert B GoldsteinEli Peli
Jul 16, 2003·BMC Ophthalmology·Hassan HashemiKazem Mohammad
Apr 13, 2002·Drugs & Aging·Morten la CourMogens Holst Nissen
Jan 10, 2014·BMC Ophthalmology·Mohan Krishna ShresthaSanduk Ruit
Jun 7, 2013·Middle East African Journal of Ophthalmology·Fatima KyariHannah Faal
Dec 25, 2004·Journal of Cataract and Refractive Surgery·Jost B JonasHans-Joachim Bender
Jan 18, 2006·Journal of Biomedical Optics·Georg SchueleRalf Brinkmann
Apr 24, 2001·The British Journal of Ophthalmology·B SeetA S Lim
Mar 27, 2002·The British Journal of Ophthalmology·R DandonaG N Rao
May 19, 2004·The British Journal of Ophthalmology·A FotouhiUNKNOWN Tehran Eye Study
Dec 10, 2008·Archives of Ophthalmology·Barbara E K KleinRonald Klein
Jun 30, 2000·Clinical Eye and Vision Care·S L Lim, M T Dunbar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.